- US Capitol Capsule: FDA barks about state restrictions, but where's the bite?
- ViiV tops reputation survey while Gilead suffers on pricing issues
- US Capitol Capsule: How to beat China in innovation race? Fine pharma
- Stockwatch: Talk is cheap as elections loom
COMMENT Other Informa Comment
- INTERVIEW: Clinuvel's Philippe Wolgen on Scenesse and the patient factor
- PROFILE: AstraZeneca's Mene Pangalos on yin and yang, not believing your own press, and his part in Soriot's vision